Prevalence of hepatitis C in patients on maintenance haemodialysis

Journal of the College of Physicians and Surgeons Pakistan

Volumn 13, Issue 1, 2003, Pages 15-18

  Gul, Ambreen ^a   Iqbal, Farrukh ^a  

^a Sheikh Zayed Postgraduate Medical Institute   (Pakistan)

Author keywords

Haemodialysis; Hepatitis C; Jaundice; Liver disease; Renal replacement therapy

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL DEPARTMENT; HUMAN; KIDNEY FAILURE; MAINTENANCE THERAPY; MALE; PAKISTAN; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PAKISTAN; PREVALENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 0037260838     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. He LF, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH, et al. Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 1987; 156: 636-90.
2. Yuasa T, Ishikawa G, Manab S, Sekiguchi S, Takechi K, Miyamura T, et al. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fiber. J Gen Virol 1991; 72: 2021-4.
3. Feinstone SM, Mihalik KB, Kamimura T, Alter HJ, London WJ, Purcell RH. Inactivation of hepatitis B virus and non-A, non-B virus by chloroform. Infect Immun 1983; 41: 816-21.
4. Houghton M, Selby M, Weiner A, Chu QL. Hepatitis C virus, structure, protein products and processing of polyprotein precursor. In: De Reesink HW. Hepatitis C virus, current study of hematol and blood transfusion 1994; 61: 1-11.
5. Weiland O, Schvarcz R. Hepatitis C, virology, epidemiology, clinical course and treatment. Scan J Gastroenterol 1992; 27: 337-8.
6. Catherine O, Stehman BN, Scotte ED, Richard J. Risk of death among chronic dialysis patients infected with Hepatitis C. Am J Kidney Dis 1998; 32: 629-34.
7. Takahashi M. Natural history of chronic Hepatitis C. Am J Gastroenterol 1993 88:240-41.
8. Dibisccceglee AM. Long-term clinical and histological follow up of chronic posttransfusion hepatitis. Hepatology 1991, 14: 969-70.
9. Shafi T, Iqbal J, Ahmad S. Prevalence of antibody to hepatitis C virus in haemodialysis patients. Pakistan J Med Res 1992; 31: 42-5.
10. Jacobs C. Medical management of dialysis patients. In: Alex M, Davidson, Stewart J, Jean Pierre Grufild, David NJ, Kew ER, (edi). Oxford text book of clinical nephrology. Oxdord: Oxford University Press 1998: 2106.
11. Abdullah A, Al Khader. HCV infection the subject of this issue. Saudi J Kid Disease and Transplant 1995; 2: 115-7.
12. Alter HJ, Pureel RH, Shih JW. Detection of antibody to Hepatitis C virus in a prospectively followed transfusion recipients with acute and chronic non A, non B hepatitis.N Engl J Med 1989; 321: 1494-500.
13. Alter HJ. New kit on block : evaluation of second generation assay for detection of antibody to hepatitis C virus. Hepatology 1992; 15: 350-3.
14. Vrielink H, Zaaijer HL, Reesink HW, Lelie PN, Vander Pocl CL. Comparison of anti-hepatitis C virus enzyme linked immunosorbent assays. Transfusion 1995; 35: 601-4.
15. Scrrciber GB, Buseh MP, Kleinman SH, Kore litz JJ. The risk of transfusion transmitted viral infection. N Engl J Med 1996, 334: 1685-90.
16. Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegarrd N, Rasmussen LS, et al. Lassen. Hepatitis C in dialysis patients: relationship to blood transfusion, dialysis and liver disease. Kidney Intr 1993; 43: 1353-6.
17. Dienstag JL, Isselbacher KJ. Acute viral hepatitis In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DS, et al. (edi). Harrison princeples of internal medicine. Vol 2, 14th ed. New York: McGraw Hill 1998; 16: 77-92.
18. Holsen DS, Harthugs, Myrma H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abusers and tatooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993; 12: 673-6.
19. Galbnaith RM. Chronic liver disease developing after HBsAg negative hepatitis in haemodialysis units. Lancet 1975; 2: 886.
20. Marmion BP, Ton Kin RW. Control of hepatitis in dialysis unit. Br Med Bull 1972; 28: 169.
21. Syndman DR. Transmission of hepatitis C associated with haemodialysis role of malfunctioning (blood leaks) in dialysis machines. J Infect Dis 1976; 134: 562.
22. Corey L. HBsAg negative hepatitis in haemodialysis unit. N Egl J Med 1975; 293: 1063.
23. Valtuille R, Fernandez JL, Berridi J, Moretto H, del Pino N, Rendo P. Evidence of hepatitis C virus passage across dialysis membrane. Nephron 1998; 80: 194-6.
24. Okuda K, Hayashi H, Yokozeki K, Kondot Kashmi T, Trie Y. Interferon treatment suggestions based on small series. J Gastroenterol Hepatol 1995; 10: 616-20.